Oral delivery of insulin with intelligent glucose-responsive switch for blood glucose regulation
Xia Zhou,Hongwei Wu,Ruimin Long,Shibin Wang,Haiwang Huang,Yanhua Xia,Pei Wang,Yifeng Lei,Yuanyuan Cai,Duanhua Cai,Yuangang Liu
DOI: https://doi.org/10.1186/s12951-020-00652-z
IF: 10.2
2020-07-14
Journal of Nanobiotechnology
Abstract:Abstract Background The traditional treatment for diabetes usually requires frequent insulin injections to maintain normoglycemia, which is painful and difficult to achieve blood glucose control. Results To solve these problems, a non-invasive and painless oral delivery nanoparticle system with bioadhesive ability was developed by amphipathic 2-nitroimidazole– l -cysteine–alginate (NI–CYS–ALG) conjugates. Moreover, in order to enhance blood glucose regulation, an intelligent glucose-responsive switch in this nanoparticle system was achieved by loading with insulin and glucose oxidase (GOx) which could supply a stimulus-sensitive turnover strategy. In vitro tests illustrated that the insulin release behavior was switched “ ON ” in response to hyperglycemic state by GOx catalysis and “ OFF ” by normal glucose levels. Moreover, in vivo tests on type I diabetic rats, this system displayed a significant hypoglycemic effect, avoiding hyperglycemia and maintaining a normal range for up to 14 h after oral administration. Conclusion The stimulus-sensitive turnover strategy with bioadhesive oral delivery mode indicates a potential for the development of synthetic GR-NPs for diabetes therapy, which may provide a rational design of proteins, low molecular drugs, as well as nucleic acids, for intelligent releasing via the oral route.
biotechnology & applied microbiology,nanoscience & nanotechnology